fingolimod hydrochloride has been researched along with iodine in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (iodine) | Trials (iodine) | Recent Studies (post-2010) (iodine) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 10,338 | 88 | 1,731 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoshikawa, S; Ito, S; Mori, K; Morohoshi, K; Nakagawa, Y; Osone, M; Ozaki, H; Takahashi, Y; Yoshida, K | 1 |
1 other study(ies) available for fingolimod hydrochloride and iodine
Article | Year |
---|---|
The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice.
Topics: Animals; Autoantibodies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Female; Fingolimod Hydrochloride; Flow Cytometry; Forkhead Transcription Factors; Iodides; Lymphocyte Count; Male; Mice; Mice, Inbred NOD; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Thyroiditis, Autoimmune | 2011 |